Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.

作者: Lucila H. Oliveira , Josiane L. Schiavinato , Mariane S. Fráguas , Antonio R. Lucena‐Araujo , Rodrigo Haddad

DOI: 10.1111/CAS.12766

关键词: EpigeneticsDNA demethylationT cellMyeloid Cell Leukemia Sequence 1 ProteinBiologyBone marrowDNA methylationCancer researchmicroRNAJurkat cells

摘要: Recent evidence has shown that deregulated expression of members the microRNA-29 (miR-29) family may play a critical role in human cancer, including hematological malignancies. However, roles miR-29 molecular pathophysiology T-cell acute lymphoblastic leukemia (T-ALL) not been investigated. Here, we show lower levels miR-29a were significantly associated with higher blast counts bone marrow and increased disease-free survival T-ALL patients. Furthermore, are extremely reduced cells compared to normal T cells. Microarray analysis following introduction synthetic mimics into Jurkat revealed downregulation several predicted targets (CDK6, PXDN, MCL1, PIK3R1, CXXC6), active passive DNA demethylation (such as DNMT3a, DNMT3b, TET TDG). Restoring Molt-4 led many genes commonly methylated T-ALL. Overall, our results suggest contribute altered epigenetic status T-ALL, highlighting its relevance physiopathology this disease.

参考文章(90)
Reut Shalgi, Ran Brosh, Moshe Oren, Yitzhak Pilpel, Varda Rotter, None, Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate. Aging (Albany NY). ,vol. 1, pp. 762- 770 ,(2009) , 10.18632/AGING.100085
Julie Borgel, Sylvain Guibert, Michael Weber, Methylated DNA Immunoprecipitation (MeDIP) from Low Amounts of Cells Methods in Molecular Biology. ,vol. 925, pp. 149- 158 ,(2012) , 10.1007/978-1-62703-011-3_9
Masao Tomonaga, Dean W. Ballard, Masahiro Fujii, Yasuaki Yamada, Naoki Yamamoto, Shuichi Ikeda, Naoki Mori, Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells Blood. ,vol. 93, pp. 2360- 2368 ,(1999) , 10.1182/BLOOD.V93.7.2360
Seong-Yeon Park, Jung Hyun Lee, Minju Ha, Jin-Wu Nam, V Narry Kim, miR-29 miRNAs activate p53 by targeting p85α and CDC42 Nature Structural & Molecular Biology. ,vol. 16, pp. 23- 29 ,(2009) , 10.1038/NSMB.1533
Jose Roman-Gomez, Antonio Jimenez-Velasco, Juan A Castillejo, Xabier Agirre, Manuel Barrios, German Navarro, Francisco J Molina, Maria J Calasanz, Felipe Prosper, Anabel Heiniger, Antonio Torres, None, Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood. ,vol. 104, pp. 2492- 2498 ,(2004) , 10.1182/BLOOD-2004-03-0954
Yuri Pekarsky, Carlo M. Croce, Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget. ,vol. 1, pp. 224- 227 ,(2010) , 10.18632/ONCOTARGET.129
Silvia Villamarín, Sylvia Mansilla, Neus Ferrer-Miralles, Waldemar Priebe, José Portugal, A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631. FEBS Journal. ,vol. 270, pp. 764- 770 ,(2003) , 10.1046/J.1432-1033.2003.03442.X
J L Mott, S Kobayashi, S F Bronk, G J Gores, mir-29 regulates Mcl-1 protein expression and apoptosis Oncogene. ,vol. 26, pp. 6133- 6140 ,(2007) , 10.1038/SJ.ONC.1210436
Dominique J. P. M. Stumpel, Pauline Schneider, Eddy H. J. van Roon, Judith M. Boer, Paola de Lorenzo, Maria G. Valsecchi, Renee X. de Menezes, Rob Pieters, Ronald W. Stam, Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood. ,vol. 114, pp. 5490- 5498 ,(2009) , 10.1182/BLOOD-2009-06-227660